Full text is available at the source.
Abstract
Anorexia nervosa (AN) is associated with high morbidity, mortality, and relapse rates, particularly in adolescents.
- AN frequently emerges during adolescence, which may impact treatment outcomes.
- Current psychological and nutritional treatments for AN result in suboptimal outcomes.
- High rates of relapse and chronicity are observed in individuals with AN.
- Preliminary evidence suggests psilocybin may have efficacy in treating psychiatric conditions characterized by rigidity.
- Clinical evidence for the use of psilocybin in adolescents with AN is currently limited.
Simplified